Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation

Autor: Nijenhuis VJ, Bennaghmouch N, Hassell M, Baan J, Jr., van Kuijk JP, Agostoni P, van 't Hof A, Kievit PC, Veenstra L, van der Harst P, van den Heuvel AF, den Heijer P, Kelder JC, Deneer VH, van der Kley F, Onorati F, Collet JP, Maisano F, Latib A, Huber K, Stella PR, Ten Berg JM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::e154a913aa1acea35df1cec61ccfcdc2

Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN-TAVI registry.

Autor: Panoulas VF; Department of cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Faculty of Medicine, Cardiovascular Sciences, National Heart and Lung Institute, Imperial College London, London, UK., Chandrasekhar J; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York, Box 1030, USA., Busi G; Interventional cardiology unit, San Raffaele Scientific Institute, Milan, Italy., Ruparelia N; Department of cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Zhang Z; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York, Box 1030, USA., Mehilli J; Department of cardiology, Ludwig-Maximilians-University of Munich, Munich, Germany., Sartori S; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York, Box 1030, USA., Lefèvre T; Institut Cardiovasculaire Paris Sud, Hôpital privé Jacques cartier, Ramsay Générale de santé, Massy, France., Presbitero P; Department of Cardiology, IRCCS Humanitas Clinical and Research Centre, Milan, Italy., Capranzano P; Department of cardiology, University of Catania, Catania, Italy., Tchetche D; Department of cardiology, Clinique Pasteur, Toulouse, France., Iadanza A; Emodinamica, Azienda Ospedaliera Universitaria Senese, Policlinico Le Scotte, Siena, Italy., Sardella G; Interventional cardiology unit, Policlinico 'Umberto I, Rome, Italy., Van Mieghem NM; Department of interventional cardiology, Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands., Meliga E; Interventional cardiology unit, Mauriziano Hospital, Turin, Italy., Dumonteil N; Department of cardiology, Clinique Pasteur, Toulouse, France., Fraccaro C; Interventional cardiology unit, University of Padova, Padova, Italy., Trabattoni D; Invasive Cardiology Unit 3, Centro Cardiologico Monzino, IRCCS, Milan, Italy., Sharma S; Department of cardiology, Mount Sinai Hospital, New York, New York, USA., Ferrer-Gracia MC; Department of Cardiology, Interventional Cardiology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain., Naber CK; Department of cardiology, Contilia Heart and Vascular Centre, Elisabeth Krankenhaus, Essen, Germany., Kievit PC; Department of cardiology, Radboud University Nijmegen Medical Center, Nijmegan,, The Netherlands., Snyder C; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York, Box 1030, USA., Sutaria N; Department of cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Sen S; Department of cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Faculty of Medicine, Cardiovascular Sciences, National Heart and Lung Institute, Imperial College London, London, UK., Malik IS; Department of cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Faculty of Medicine, Cardiovascular Sciences, National Heart and Lung Institute, Imperial College London, London, UK., Morice MC; Department of cardiology, Ludwig-Maximilians-University of Munich, Munich, Germany., Nihoyannopoulos P; Department of cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Faculty of Medicine, Cardiovascular Sciences, National Heart and Lung Institute, Imperial College London, London, UK., Petronio AS; Interventional cardiology unit, AOUP Cisanello, University Hospital, Pisa, Italy., Mehran R; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York, Box 1030, USA., Chieffo A; Interventional cardiology unit, San Raffaele Scientific Institute, Milan, Italy., Mikhail GW; Department of cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Faculty of Medicine, Cardiovascular Sciences, National Heart and Lung Institute, Imperial College London, London, UK.

Publikováno v: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2021 Feb 15; Vol. 97 (3), pp. 516-526. Date of Electronic Publication: 2020 Aug 31.

Feasibility and Outcomes of Transcatheter Aortic Valve Implantation Using the Left Axillary Artery as Primary Access Site.

Autor: van der Wulp K; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Verkroost MWA; Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., van Wely MH; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Gehlmann HR; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Van Garsse LAFM; Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., Noyez L; Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., Brouwer MA; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Kievit PC; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., De Boer MJ; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Suryapranata H; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Morshuis WJ; Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., van Royen N; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: niels.vanroyen@radboudumc.nl.

Publikováno v: The Annals of thoracic surgery [Ann Thorac Surg] 2019 Feb; Vol. 107 (2), pp. 546-552. Date of Electronic Publication: 2018 Oct 04.

Effect of dipyridamole on myocardial reperfusion injury: A double-blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery.

Autor: El Messaoudi, S, Wouters, CW, van Swieten, HA, Pickkers, P, Noyez, L, Kievit, PC, Abbink, EJ, Rasing‐Hoogveld, A, Bouw, TP, Peters, JG, Coenen, MJH, Donders, ART, Riksen, NP, Rongen, GA

Publikováno v: Clinical Pharmacology & Therapeutics; Apr2016, Vol. 99 Issue 4, p381-389, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.